Is early-onset cancer an emerging global epidemic? Current evidence and future implications

T Ugai, N Sasamoto, HY Lee, M Ando… - Nature Reviews …, 2022 - nature.com
Over the past several decades, the incidence of early-onset cancers, often defined as
cancers diagnosed in adults< 50 years of age, in the breast, colorectum, endometrium …

Wilms tumour

F Spreafico, CV Fernandez, J Brok, K Nakata… - Nature Reviews …, 2021 - nature.com
Wilms tumour (WT) is a childhood embryonal tumour that is paradigmatic of the intersection
between disrupted organogenesis and tumorigenesis. Many WT genes play a critical (non …

Patterns in cancer incidence among people younger than 50 years in the US, 2010 to 2019

B Koh, DJH Tan, CH Ng, CE Fu, WH Lim… - JAMA Network …, 2023 - jamanetwork.com
Importance Emerging data suggest that the incidence of early-onset cancers, defined as
cancers diagnosed in people younger than 50 years, is increasing, but updated data are …

Ovarian damage from chemotherapy and current approaches to its protection

N Spears, F Lopes, A Stefansdottir… - Human reproduction …, 2019 - academic.oup.com
Background Anti-cancer therapy is often a cause of premature ovarian insufficiency and
infertility since the ovarian follicle reserve is extremely sensitive to the effects of …

[PDF][PDF] 2040

O Vision - Supreme Council for Planning, Muscat, Sultanate of …, 2019 - meru.go.ke
Where do we want to see Meru County 20 to 100 years from now? How do we empower
Meru people to achieve their fullest potential? How do we make Meru County a place of …

Improving quality and quantity of life for childhood cancer survivors globally in the twenty-first century

MJ Ehrhardt, KR Krull, N Bhakta, Q Liu… - Nature Reviews …, 2023 - nature.com
The contributions of cooperative groups to performing large-cohort clinical trials and long-
term survivorship studies have facilitated advances in treatment, supportive care and …

Anti-Müllerian hormone as a marker of ovarian reserve and premature ovarian insufficiency in children and women with cancer: a systematic review

RA Anderson, D Cameron, F Clatot… - Human reproduction …, 2022 - academic.oup.com
BACKGROUND Female patients undergoing anticancer treatment are at elevated risk of
adverse ovarian outcomes including infertility and premature ovarian insufficiency (POI) …

[PDF][PDF] Ovarian microenvironment: challenges and opportunities in protecting against chemotherapy-associated ovarian damage

Y Guo, L Xue, W Tang, J Xiong, D Chen… - Human …, 2024 - academic.oup.com
BACKGROUND Chemotherapy-associated ovarian damage (CAOD) is one of the most
feared short-and long-term side effects of anticancer treatment in premenopausal women …

Impact of COVID-19 on female fertility: a systematic review and meta-analysis protocol

F Li, H Lu, Q Zhang, X Li, Q Liu, Q Yang, L Qiang - BMJ open, 2021 - bmjopen.bmj.com
Introduction The increased social and economic burden caused by the novel COVID-19
outbreak is gradually becoming a worrisome issue for the health sector. The novel …

[HTML][HTML] Cancer survivorship: reproductive health outcomes should be included in standard toxicity assessments

RA Anderson, F Clatot, I Demeestere… - European Journal of …, 2021 - Elsevier
It is well established that cancer and its treatment, whether by chemotherapy, radiotherapy,
hormone therapy, or surgery, can adversely impact reproductive function in both women and …